15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Dolby Laboratories, 3 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $74.00 to $114.00, a moderate spread. The average target of $90.75 sits 73% above the current $52.50. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.21 next quarter toward $4.59 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy375%
Hold125%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Dolby Laboratories.
As of Jul, 3 of 4 firms rate DLB a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
DLB EPS & revenue forecast
EPS · NEXT QUARTER
$1.21
Range $1.20 – $1.22 · 2 analysts · +22% YoY
Next period, 2 analysts expect Dolby Laboratories to earn $1.21 a share (range $1.20 – $1.22), versus $0.99 a year earlier. Full-year consensus is $4.32, growing to $4.59 the year after.
REVENUE · NEXT QUARTER
$351.9M
Range $341.9M – $356.9M · 2 analysts · +15% YoY
Revenue is expected to reach $351.9M (range $341.9M – $356.9M), +14.6% year-over-year. Full-year consensus is $1.4B, rising to $1.5B next year.
Top analysts covering Dolby Laboratories
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on DLB.
#1
James Goss
Barrington Research · Rank #336
Buy
$100.00+90.5% to target
Overall win rate
25%
+ Follow
#2
SF
Steven Frankel
Rosenblatt
Buy
$85.00+61.9% to target
Coverage
—
+ Follow
#3
PS
Patrick Sholl
Barrington Research
Buy
$90.00+71.4% to target
Coverage
—
+ Follow
#4
Ivan Feinseth
Tigress Financial
Buy
$114.00+117.1% to target
Coverage
—
+ Follow
#5
Vikram Kesavabhotla
Baird
Hold
$74.00+41.0% to target
Coverage
—
+ Follow
DLB stock forecast FAQ
What is DLB's average 12-month price target?+
The 4 analysts with a live target average $90.75 for Dolby Laboratories over the next 12 months, ranging from a $114.00 high to a $74.00 low.
Is DLB stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 3 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for DLB?+
The Street-high target is $114.00 (Tigress Financial), and the Street-low is $74.00 (Baird). The average of all 4 active targets is $90.75.
How many Wall Street analysts cover DLB?+
4 analysts have an active rating on Dolby Laboratories, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering DLB?+
Among analysts who currently cover DLB, James Goss of Barrington Research has the strongest overall Quantellect track record (Rank #336). Their current call is Buy with a $100.00 target.
What is Dolby Laboratories's projected EPS for next quarter?+
The consensus estimate is $1.21 per share (range $1.20 – $1.22) across 2 analysts. Full-year EPS is projected at $4.32, rising to $4.59 the following year.
How much revenue is Dolby Laboratories expected to report next quarter?+
Consensus revenue is $351.9M (range $341.9M – $356.9M). Full-year revenue is projected at $1.4B, growing to $1.5B next year.
Have analysts been upgrading or downgrading DLB lately?+
As of Jul, 3 of 4 firms rate DLB a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their DLB calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
